Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoCellect Biomedical develops and commercializes microfluidic flow cytometry platforms that enable gentle, high viability cell sorting for applications in drug discovery, single-cell omics, antibody discovery, cloning, gene editing, stem cell research, plant biology, genomics, and basic biomedical research. Their products are used by researchers worldwide with nearly 400 placements as of late 2024. The company continues to innovate with new image-based solutions such as the VERLO platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoCellect Biomedical.